Haleon plc (NYSE:HLN) Shares Sold by Franklin Resources Inc.

Franklin Resources Inc. lowered its position in shares of Haleon plc (NYSE:HLN) by 1.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 254,819 shares of the company’s stock after selling 4,230 shares during the period. Franklin Resources Inc.’s holdings in Haleon were worth $2,574,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Fortitude Family Office LLC purchased a new position in Haleon during the 3rd quarter worth approximately $28,000. Toronto Dominion Bank grew its position in shares of Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after acquiring an additional 3,470 shares during the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Haleon in the 3rd quarter valued at $57,000. BOKF NA raised its position in Haleon by 68.8% in the 2nd quarter. BOKF NA now owns 6,972 shares of the company’s stock valued at $58,000 after purchasing an additional 2,842 shares during the last quarter. Finally, Rothschild Investment LLC acquired a new stake in Haleon during the 2nd quarter worth $60,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have commented on HLN. Morgan Stanley lifted their price objective on shares of Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research note on Friday, September 20th. UBS Group upgraded Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Haleon currently has a consensus rating of “Buy” and a consensus target price of $10.95.

Haleon Stock Performance

NYSE:HLN opened at $9.74 on Thursday. The firm has a market cap of $44.09 billion, a price-to-earnings ratio of 28.65, a price-to-earnings-growth ratio of 2.95 and a beta of 0.28. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80. The firm’s fifty day moving average price is $9.69 and its 200 day moving average price is $9.59.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.